Welcome to Cangen

Cangen is a global pharmaceutical company acting as a
diversified provider of Cannabis-based therapeutics.

Vision


The vision of Cangen is

- To offer ‘best in cannabis’ care for our stakeholders;
-To make a positive difference to individuals, family, and society with medical cannabis-based formulations
-To be a great place to work.


Mission

In support of Cangen’s vision, the management has prepared the following mission:

- To offer ‘best in cannabis’ care for our stakeholders
- To make a positive difference to individuals, family, and society with medical cannabis-based formulations
- To be a great place to work

Key areas of impact will be on enhancing personal well-being and raising awareness on the impact of Cannabis, delivering and addressing a long-term strong, vibrant, sustainable and informed community. Our aim is to deliver concrete value to Cangen’s stakeholders and promote the development of sustainable global market in cannabis-based therapeutics

A new Canabies Technology


Cangen is an early stage pharmaceutical company with its global headquarter located in Toronto, Canada. The Company aspires to develop and sell products in the rapidly growing market around the globe. Cangen specializes in cannabis-based therapeutic medications and treatments for various illnesses.

Cangen’s primary strategy is to develop, manufacture, and commercialize Abbreviated New Drug Applications (ANDAs) and New Drug Applications (NDAs). However, currently in order to offer our customers a varied and broad product portfolio within the cannabis-based therapeutics, we will also be acquiring or licensing additional products that fulfill our niche


services-img1






services-img1

A new Canabies Technology


Cangen's products are marketed through national wholesalers and distributors, and direct to major warehousing customers. Our target markets include wholesaler multi-source programs, chain of drug stores, managed healthcare providers, and institutional (government or private) healthcare facilities.

Cangen aspires to become a pioneer in the area of standardization, production, quality assurance, distribution, and documentation of medical cannabis globally. Cangen brings together all the stakeholders (the manufacturers, suppliers, patients, phar maceutical industries, and the regulatory authorities). Our goal is the barrier-free supply of cannabis for medical purpose to the patients, as well as the legalization of cannabis for recreational use.



Introducing SOMA




What is Soma?


SOMA is an Ethereum (ERC 20) token; the name SOMA has a very intriguing history behind it. In Vedic India, the word 'soma' was stated in Veda to be a divine and sacred plant, with its miraculous properties, which enlightened the worshipper and the person who drank its juice. There has been much speculation about the most likely identity of the original plant. However, according to recent philological and archaeological studies, and in addition, direct preparation instructions confirm in the Rig Vedic Hymns (Vedic period) Ancient Soma most likely consisted of Poppy, Phaedra/Ephedra (plant) and Cannabis.

SOMA Ethereum (ERC 20) token creates a community to connect the cannabis industry. Our solution is solely targeted to the cannabis industry and we intend to transform the cannabis market.



Why Soma?


We provide a convenient and secure way to make payment for cannabis products in the cannabis industry. Our goal is to offer solutions to curb the lack of banking and payment system for legal cannabis businesses. We are transforming the cannabis industry, with our Ethereum-based (ERC 20) token. SOMA is the next big thing in the cannabis industry.

In order to compliance with the law, at CANGEN, we have created smart contracts for the cannabis industry. Producers and sellers have the opportunity to standardize and document their production and distribution based on blockchain technology. We, our partners, and other stakeholders accept payments in SOMA tokens, with the ability to toggle tokens locally and load them onto a membership card (based on an ERC20 tokens) stored on the blockchain.
By participating in the Cangen ICO, you invest directly in the global cannabis-based pharma industry!





Read Our Whitepaper


Cangen initial coin offering (ICO) contains all important information about our ICO project, i.e. the business plan of our company. Our white paper, in brief, outlines everything you have to know about the project  — our company information, our products, structure, mission, benefits, team, Target Users, Problem vs. Solution, Competition in the market, Token Value, Token Distribution, Roadmap, Use of funds, Terms and conditions, Diagrams and statistics, and future plans. Interested? Please take your time to review. Don’t miss Cangen ICO!!!

Team Behind The Project




S.R. Pandi-Perumal

Pandi-Perumal is the founder and the President and Chief Executive Officer of Cangen. He will be also part of Company's Scientific Advisory Board. He has broad medical and biological knowledge. Pandi will direct and steer the company in all areas of company's successful operation. Along with the Chairman of Scientific Advisory Board (SAB), Pandi will help to establish a state of the art research and development (R&D) facility to collaborate with stakeholders worldwide. His online credentials can be viewed at http://pandi-perumal.blogspot.com.




Robin B. Williams

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.




Frank Bauer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

"The illegality of cannabis is outrageous, an impediment
to full utilization of a drug which helps produce the serenity and insight, sensitivity and fellowship
so desperately needed in this increasingly mad and dangerous world."

— Carl Sagan